APA (7th ed.) Citation

S, P., OS, M., T, N., M, K., H, H., J, R., . . . PJ, L. (2024). Plasma symmetric dimethylarginine as a metabolite biomarker of severe acute ischemic stroke. Frontiers in neurology, 15, 1472424. https://doi.org/10.3389/fneur.2024.1472424

Chicago Style (17th ed.) Citation

S, Pihlasviita, et al. "Plasma Symmetric Dimethylarginine as a Metabolite Biomarker of Severe Acute Ischemic Stroke." Frontiers in Neurology 15 (2024): 1472424. https://doi.org/10.3389/fneur.2024.1472424.

MLA (9th ed.) Citation

S, Pihlasviita, et al. "Plasma Symmetric Dimethylarginine as a Metabolite Biomarker of Severe Acute Ischemic Stroke." Frontiers in Neurology, vol. 15, 2024, p. 1472424, https://doi.org/10.3389/fneur.2024.1472424.